3/15/2013
Please join us for the NIH 2013 Women’s History Month Program. The national theme for the 2013 Women’s History Month is "Women Inspiring Innovation Through Imagination: Celebrating Women in Science, Technology, Engineering and Mathematics." The theme provides an opportunity for the NIH community to celebrate the achievements of women in STEM and reflect on how we can better equip women and girls to enter and succeed in STEM fields.
Our keynote speaker is Dr. Lydia Villa-Komaroff, an internationally-recognized molecular biologist who has performed groundbreaking research and has held key leadership roles in academia and the private sector. You can learn more about Dr. Villa-Komaroff¹s remarkable story and achievements at
http://www.makers.com/lydia-villa-komaroff
Dr. Villa-Komaroff presentation is entitled “From Cloning to Cell Therapies: A Life in Science.”
Other NIH program participants include Lawrence Tabak, D.D.S., Ph.D., Deputy Director, NIH; Susan Maier, Ph.D., Deputy Director, Office of Research on Women’s Health; Sharon Milgram, Ph.D., Director, Office of Intramural Training & Education; and Debra Chew, Esq., Director, Office of Equal Opportunity and Diversity Management.
Air date: 3/21/2013 1:30:00 PM
3/15/2013
The NCI Director's Consumer Liaison Group (DCLG) is a federal advisory committee comprised of high profile patients, health professionals and career advocates who provide recommendations to the Director of NCI on behalf of the general public. The DCLG members meet for two days, and consider reports from NCI scientists on the priorities that the Director has asked the members to advise him on. At conclusion of the meeting, action items are defined, and the DCLG members summarize decisions and action items for the Director. Additionally, these meetings serve as a forum for the advocacy community and allow the DCLG to determine plans of action for the future.
Air date: 3/19/2013 9:00:00 AM
3/15/2013
The NCI Director's Consumer Liaison Group (DCLG) is a federal advisory committee comprised of high profile patients, health professionals and career advocates who provide recommendations to the Director of NCI on behalf of the general public. The DCLG members meet for two days, and consider reports from NCI scientists on the priorities that the Director has asked the members to advise him on. At conclusion of the meeting, action items are defined, and the DCLG members summarize decisions and action items for the Director. Additionally, these meetings serve as a forum for the advocacy community and allow the DCLG to determine plans of action for the future.
Air date: 3/18/2013 9:00:00 AM
3/14/2013
CC Grand Rounds: (1) Participants' Perspectives of Clinical Research Processes: Can We Improve 'How We Do' 'What We Do?' (2) Walk This Way: Novel Approaches for Training Children with Cerebral Palsy to Walk Better
For more information go to
http://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 3/27/2013 12:00:00 PM
3/14/2013
Almost everyone has allergies, ranging from minor inconveniences to life threatening situations. Are allergies becoming more prevalent? Why might your immune system react to seemingly harmless substances as though they are threats? Join us as we look at responses to food, drug, and environmental allergens. You will learn about therapies for allergic reactions and prevention of allergies in children and adults. After viewing the forum, please fill in and submit an on-line course evaluation
http://surveyconsole.com/t/AB0zTZDX7n
For more information go to
http://nih-extramural-intranet.od.nih.gov/nih/training/step/step_training_20130319.htmAir date: 3/19/2013 9:00:00 AM
3/14/2013
Dr. Kohane will discuss how to quickly create a national-scale rapid learning network (RLN) for CER to advance the practice of "precision medicine." The RLN will capture requisite clinical data and genomics, and feed insights back to the biomedical enterprise at the point of care in continuous, rapid-learning cycles. By generating evidence from the real-world experience of millions of patients, the RLN will underpin decision-making in health care and relieve dependence on the slow and costly logistics of traditional clinical trials. The RLN can have bidirectional communication to and from the point of care: including data on all patients, their therapies, their genes, and their outcomes, and guide therapeutic decision making.
Dr. Kohane will address barriers to achieving a RLN: 1) EHRs do not enable uniform and modifiable data collection, nor generation of cohorts and trials across sites of care (e.g., randomization of patients in pragmatic trials), nor integrate research data that complements clinical data; 2) EHRs do not enable translation of research findings back to the point of care (e.g., pharmacogenomically-based personalized dose adjustment); and 3) EHRs store data in proprietary formats not designed to share or federate data.
Isaac (Zak) Kohane is the director of the Boston Children’s Hospital Informatics Program and is Henderson Professor of Pediatrics and Health Sciences and Technology at Harvard Medical School (HMS). He is also the co-Director of the HMS Center for Biomedical Informatics and Director of the HMS Countway Library of Medicine. Dr. Kohane leads multiple collaborations at Harvard Medical School and its hospital affiliates in the use of genomics and computer science to study diseases through the perspective of biological development. He has developed several computer systems to allow multiple hospital systems to be used as “living laboratories” to study the genetic basis of disease while preserving patient privacy. Among these, the i2b2 (Informatics for Integrating Biology and the Bedside) National Computing Center has been deployed at over 52 academic health centers internationally.
Air date: 3/21/2013 3:30:00 PM
3/14/2013
Neuroscience Seminar Series
Dr. Haber's laboratory investigates the neural network that underlies incentive-based learning and decision-making leading to the development of action plans. The cortico-basal ganglia system is at the center of this circuit and comprises a diverse group of structures involved in reward and motivation, cognition, and motor control. The consequence of basal ganglia dysfunction is emphasized in the range of diseases that involve it, including mental health disorders such as obsessive-compulsive disorder, drug abuse and addiction, and schizophrenia, and motor control disorders including Parkinson’s disease. One set of experiments in Dr. Haber's laboratory address the hypothesis that the cortico-basal ganglia network processes information through both parallel and integrative circuits. A second set of studies focus on the pathway trajectories from different prefrontal areas to their targets. A third set of experiments focus on which pathways and terminals fields are likely to be involved in the therapeutic effects of during deep brain stimulation (DBS). A fourth set of studies address the changes in terminal fields and white matter tracts during postnatal development.
For more information go to
http://neuroseries.info.nih.govAir date: 3/18/2013 12:00:00 PM
3/11/2013
NBS Travel HPOC meeting to discuss current travel system issues and updates.
Air date: 4/1/2013 10:00:00 AM
3/7/2013
It is common for scientists to present their research findings to the peers at scientific poster sessions. Summer Poster Day, held in the Natcher Conference Center in August, provides the opportunity for NIH summer interns to present their research. Last year more than 750 interns participated. This workshop will help prepare you for Poster Day or any other opportunity you have to present your work in poster format. The workshop will focus on selecting and organizing data, the key sections of a successful poster, layout and font selection, and poster presentation techniques.
For more information go to
https://www.training.nih.govAir date: 7/11/2013 2:00:00 PM
